4//SEC Filing
Sveen Christopher D. 4
Accession 0001140361-23-029889
CIK 0001038133other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:27 PM ET
Size
25.8 KB
Accession
0001140361-23-029889
Insider Transaction Report
Form 4
HESKA CORPHSKA
Sveen Christopher D.
CAO & General Counsel
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2023-06-13−7,827→ 0 totalExercise: $71.84Exp: 2029-09-23→ Common Stock (7,827 underlying) - Award
Common Stock
2023-06-13+15,157→ 23,643 total - Award
Common Stock
2023-06-13+3,948→ 27,591 total - Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−27,591$3,310,920→ 0 total - Award
Non-Qualified Stock Option (right to buy)
2022-02-28+10,000→ 10,000 totalExercise: $60.94From: 2022-02-28Exp: 2030-04-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2023-06-13−2→ 0 totalExercise: $60.94Exp: 2030-04-15→ Common Stock (2 underlying) - Disposition to Issuer
Performance Shares
2023-06-13−750→ 0 totalExp: 2025-03-31→ Common Stock (750 underlying) - Award
Non-Qualified Stock Option (right to buy)
2023-06-13+25,000→ 35,000 totalExercise: $60.94From: 2023-06-13Exp: 2030-04-15→ Common Stock (25,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2023-06-13−35,000→ 0 totalExercise: $60.94Exp: 2030-04-15→ Common Stock (35,000 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2023-06-13−4,173→ 0 totalExercise: $71.84Exp: 2029-09-23→ Common Stock (4,173 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2023-06-13−9,998→ 0 totalExercise: $60.94Exp: 2030-04-15→ Common Stock (9,998 underlying)
Footnotes (10)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
- [F10]These stock options of the Issuer vested in three equal installments on September 24, 2020, September 24, 2021 and September 24, 2022.
- [F2]Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.
- [F3]Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
- [F4]Pursuant to the Merger Agreement, these performance shares of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger and canceled in the merger in exchange for an amount in cash equal to $120.00 per share.
- [F5]1,500 performance shares previously vested and settled.
- [F6]Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.
- [F7]Pursuant to the Merger Agreement, these stock options of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
- [F8]Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.
- [F9]These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.
Documents
Issuer
HESKA CORP
CIK 0001038133
Entity typeother
Related Parties
1- filerCIK 0001810123
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:27 PM ET
- Size
- 25.8 KB